Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older Adults | Neurology | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
1.
American Academy of Sleep Medicine.  The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Darien, IL: American Academy of Sleep Medicine; 2005.
2.
American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th ed, Text Revision. Washington, DC: American Psychiatric Association; 2000.
3.
Ohayon  MM.  Epidemiology of insomnia: what we know and what we still need to learn.  Sleep Med Rev. 2002;6(2):97-111. PubMedGoogle ScholarCrossref
4.
Shochat  T, Umphress  J, Israel  AG, Ancoli-Israel  S.  Insomnia in primary care patients.  Sleep. 1999;22(suppl 2):S359-S365. PubMedGoogle Scholar
5.
Simon  GE, VonKorff  M.  Prevalence, burden, and treatment of insomnia in primary care.  Am J Psychiatry. 1997;154(10):1417-1423. PubMedGoogle ScholarCrossref
6.
Taylor  DJ, Mallory  LJ, Lichstein  KL, Durrence  HH, Riedel  BW, Bush  AJ.  Comorbidity of chronic insomnia with medical problems.  Sleep. 2007;30(2):213-218. PubMedGoogle ScholarCrossref
7.
Morin  CM, Bélanger  L, LeBlanc  M,  et al.  The natural history of insomnia: a population-based 3-year longitudinal study.  Arch Intern Med. 2009;169(5):447-453. PubMedGoogle ScholarCrossref
8.
Buysse  DJ, Germain  A, Moul  DE.  Diagnosis, epidemiology and consequences of insomnia.  Prim Psychiatry. 2005;12(8):37-44.Google Scholar
9.
Vgontzas  AN, Liao  D, Bixler  EO, Chrousos  GP, Vela-Bueno  A.  Insomnia with objective short sleep duration is associated with a high risk for hypertension.  Sleep. 2009;32(4):491-497. PubMedGoogle ScholarCrossref
10.
Avidan  AY, Fries  BE, James  ML, Szafara  KL, Wright  GT, Chervin  RD.  Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes.  J Am Geriatr Soc. 2005;53(6):955-962. PubMedGoogle ScholarCrossref
11.
Bliwise  DL.  Normal aging.  In: Kryger  MH, Roth  T, Dement  WC, eds.  Principles and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005.Google Scholar
12.
Aparasu  RR, Mort  JR, Brandt  H.  Psychotropic prescription use by community-dwelling elderly in the United States.  J Am Geriatr Soc. 2003;51(5):671-677. PubMedGoogle ScholarCrossref
13.
Bloom  HG, Ahmed  I, Alessi  CA,  et al.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.  J Am Geriatr Soc. 2009;57(5):761-789. PubMedGoogle ScholarCrossref
14.
Glass  J, Lanctôt  KL, Herrmann  N, Sproule  BA, Busto  UE.  Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.  BMJ. 2005;331(7526):1169PubMedGoogle ScholarCrossref
15.
Schutte-Rodin  S, Broch  L, Buysse  D, Dorsey  C, Sateia  M.  Clinical guideline for the evaluation and management of chronic insomnia in adults.  J Clin Sleep Med. 2008;4(5):487-504. PubMedGoogle Scholar
16.
Smith  MT, Perlis  ML, Park  A,  et al.  Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.  Am J Psychiatry. 2002;159(1):5-11. PubMedGoogle ScholarCrossref
17.
Krystal  AD, Walsh  JK, Laska  E,  et al.  Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.  Sleep. 2003;26(7):793-799. PubMedGoogle ScholarCrossref
18.
Krystal  AD, Erman  M, Zammit  GK, Soubrane  C, Roth  T, ZOLONG Study Group.  Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.  Sleep. 2008;31(1):79-90. PubMedGoogle ScholarCrossref
19.
Goodwin  RD, Hasin  DS.  Sedative use and misuse in the United States.  Addiction. 2002;97(5):555-562. PubMedGoogle ScholarCrossref
20.
Woolcott  JC, Richardson  KJ, Wiens  MO,  et al.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.  Arch Intern Med. 2009;169(21):1952-1960. PubMedGoogle ScholarCrossref
21.
Hamai  Y, Fujii  T, Yamashita  T,  et al.  Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia.  Am J Reprod Immunol. 1997;38(2):89-93. PubMedGoogle ScholarCrossref
22.
Morin  CM, Gaulier  B, Barry  T, Kowatch  RA.  Patients' acceptance of psychological and pharmacological therapies for insomnia.  Sleep. 1992;15(4):302-305. PubMedGoogle ScholarCrossref
23.
Morin  CM, Bootzin  RR, Buysse  DJ, Edinger  JD, Espie  CA, Lichstein  KL.  Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004).  Sleep. 2006;29(11):1398-1414. PubMedGoogle ScholarCrossref
24.
Irwin  MR, Cole  JC, Nicassio  PM.  Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age.  Health Psychol. 2006;25(1):3-14. PubMedGoogle ScholarCrossref
25.
Germain  A, Moul  DE, Franzen  PL,  et al.  Effects of a brief behavioral treatment for late-life insomnia: preliminary findings.  J Clin Sleep Med. 2006;2(4):403-406. PubMedGoogle Scholar
26.
National Institutes of Health.  NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults. http://consensus.nih.gov/2005/insomniastatement.pdf. Accessed November 6, 2010
27.
Kroenke  K, Spitzer  R.  The PHQ-9: a new depression and diagnostic severity measure.  Psychiatr Ann. 2002;32(9):509-521.Google ScholarCrossref
28.
Borbely  AA, Achermann  P.  Sleep homeostasis and models of sleep regulation.  In: Kryger  MH, Roth  T, Dement  WE, eds.  Principles and Practice of Sleep Medicine3rd ed. Philadelphia, PA: W.B. Saunders Co; 2000:377-390.Google Scholar
29.
Morin  CM, Culbert  JP, Schwartz  SM.  Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy.  Am J Psychiatry. 1994;151(8):1172-1180. PubMedGoogle ScholarCrossref
30.
American Academy of Sleep Medicine.  Insomnia: The Inability to Fall Asleep or Stay Asleep. Westchester, IL: American Academy of Sleep Medicine; 2000.
31.
American Academy of Sleep Medicine.  Sleep as We Grow Older: Learning How Aging Affects Sleep Westchester, IL: American Academy of Sleep Medicine; 2001.
32.
American Academy of Sleep Medicine.  Sleep Hygiene: Behaviors That Promote Sound Sleep. Westchester, IL: American Academy of Sleep Medicine; 2002.
33.
Adler  NE, Epel  ES, Castellazzo  G, Ickovics  JR.  Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women.  Health Psychol. 2000;19(6):586-592. PubMedGoogle ScholarCrossref
34.
Adler  N, Singh-Manoux  A, Schwartz  J, Stewart  J, Matthews  K, Marmot  MG.  Social status and health: a comparison of British civil servants in Whitehall-II with European- and African-Americans in CARDIA.  Soc Sci Med. 2008;66(5):1034-1045. PubMedGoogle ScholarCrossref
35.
Charlson  ME, Pompei  P, Ales  KL, MacKenzie  CR.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.  J Chronic Dis. 1987;40(5):373-383. PubMedGoogle ScholarCrossref
36.
Katz  JN, Chang  LC, Sangha  O, Fossel  AH, Bates  DW.  Can comorbidity be measured by questionnaire rather than medical record review?  Med Care. 1996;34(1):73-84. PubMedGoogle ScholarCrossref
37.
Ware  JE  Jr, Sherbourne  CD.  The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection.  Med Care. 1992;30(6):473-483. PubMedGoogle ScholarCrossref
38.
Ware  JE, Snow  KK, Kosinski  M.  SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: Health Institute, New England Medical Center; 1993.
39.
Hamilton  M.  A rating scale for depression.  J Neurol Neurosurg Psychiatry. 1960;23:56-62. PubMedGoogle ScholarCrossref
40.
Hamilton  M.  The assessment of anxiety states by rating.  Br J Med Psychol. 1959;32(1):50-55. PubMedGoogle ScholarCrossref
41.
Folstein  MF, Folstein  SE, McHugh  PR.  “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician.  J Psychiatr Res. 1975;12(3):189-198. PubMedGoogle ScholarCrossref
42.
Buysse  DJ, Reynolds  CF  III, Monk  TH, Berman  SR, Kupfer  DJ.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.  Psychiatry Res. 1989;28(2):193-213. PubMedGoogle ScholarCrossref
43.
Johns  MW.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.  Sleep. 1991;14(6):540-545. PubMedGoogle ScholarCrossref
44.
Monk  TH, Reynolds  CF, Kupfer  DJ,  et al.  The Pittsburgh Sleep Diary.  J Sleep Res. 1994;3(2):111-120. PubMedGoogle ScholarCrossref
45.
Morin  CM, Colecchi  C, Stone  J, Sood  RK, Brink  D.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.  JAMA. 1999;281(11):991-999. PubMedGoogle ScholarCrossref
46.
Buysse  DJ, Ancoli-Israel  S, Edinger  JD, Lichstein  KL, Morin  CM.  Recommendations for a standard research assessment of insomnia.  Sleep. 2006;29(9):1155-1173. PubMedGoogle ScholarCrossref
47.
Yang  M, Morin  CM, Schaefer  K, Wallenstein  GV.  Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference.  Curr Med Res Opin. 2009;25(10):2487-2494. PubMedGoogle ScholarCrossref
48.
Lichstein  KL, Riedel  BW, Wilson  NM, Lester  KW, Aguillard  RN.  Relaxation and sleep compression for late-life insomnia: a placebo-controlled trial.  J Consult Clin Psychol. 2001;69(2):227-239. PubMedGoogle ScholarCrossref
49.
Nowell  PD, Mazumdar  S, Buysse  DJ, Dew  MA, Reynolds  CF  III, Kupfer  DJ.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.  JAMA. 1997;278(24):2170-2177. PubMedGoogle ScholarCrossref
50.
Edinger  JD, Wohlgemuth  WK, Radtke  RA, Marsh  GR, Quillian  RE.  Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial.  JAMA. 2001;285(14):1856-1864. PubMedGoogle ScholarCrossref
51.
Morin  CM, Vallières  A, Guay  B,  et al.  Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.  JAMA. 2009;301(19):2005-2015. PubMedGoogle ScholarCrossref
52.
Edinger  JD, Fins  AI, Sullivan  RJ  Jr,  et al.  Sleep in the laboratory and sleep at home: comparisons of older insomniacs and normal sleepers.  Sleep. 1997;20(12):1119-1126. PubMedGoogle ScholarCrossref
53.
Edinger  JD, Glenn  DM, Bastian  LA,  et al.  Sleep in the laboratory and sleep at home II: comparisons of middle-aged insomnia sufferers and normal sleepers.  Sleep. 2001;24(7):761-770. PubMedGoogle ScholarCrossref
54.
Buysse  DJ, Germain  A, Hall  ML,  et al.  EEG spectral analysis in primary insomnia: NREM period effects and sex differences.  Sleep. 2008;31(12):1673-1682. PubMedGoogle ScholarCrossref
55.
Manconi  M, Ferri  R, Sagrada  C,  et al.  Measuring the error in sleep estimation in normal subjects and in patients with insomnia.  J Sleep Res. 2010;19(3):478-486. PubMedGoogle ScholarCrossref
56.
Edinger  JD, Sampson  WS.  A primary care “friendly” cognitive behavioral insomnia therapy.  Sleep. 2003;26(2):177-182. PubMedGoogle ScholarCrossref
57.
Espie  CA, Inglis  SJ, Tessier  S, Harvey  L.  The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice.  Behav Res Ther. 2001;39(1):45-60. PubMedGoogle ScholarCrossref
58.
Espie  CA, MacMahon  KM, Kelly  HL,  et al.  Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice.  Sleep. 2007;30(5):574-584. PubMedGoogle ScholarCrossref
59.
Rybarczyk  B, Stepanski  E, Fogg  L, Lopez  M, Barry  P, Davis  A.  A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults.  J Consult Clin Psychol. 2005;73(6):1164-1174. PubMedGoogle ScholarCrossref
60.
Ritterband  LM, Thorndike  FP, Gonder-Frederick  LA,  et al.  Efficacy of an Internet-based behavioral intervention for adults with insomnia.  Arch Gen Psychiatry. 2009;66(7):692-698. PubMedGoogle ScholarCrossref
61.
Espie  CA.  “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment.  Sleep. 2009;32(12):1549-1558. PubMedGoogle ScholarCrossref
Original Investigation
January 24, 2011

Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older Adults

Author Affiliations

Author Affiliations: Sleep Medicine Institute and Department of Psychiatry, University of Pittsburgh School of Medicine (Drs Buysse, Germain, Franzen, Reynolds, and Monk and Mss Brar, Fletcher, Begley, and Houck), and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health (Dr Mazumdar), Pittsburgh, Pennsylvania; and Cleveland Clinic Sleep Disorders Center, Cleveland, Ohio (Dr Moul).

Arch Intern Med. 2011;171(10):887-895. doi:10.1001/archinternmed.2010.535
Abstract

Background  Chronic insomnia is a common health problem with substantial consequences in older adults. Cognitive behavioral treatments are efficacious but not widely available. The aim of this study was to test the efficacy of brief behavioral treatment for insomnia (BBTI) vs an information control (IC) condition.

Methods  A total of 79 older adults (mean age, 71.7 years; 54 women [70%]) with chronic insomnia and common comorbidities were recruited from the community and 1 primary care clinic. Participants were randomly assigned to either BBTI, consisting of individualized behavioral instructions delivered in 2 intervention sessions and 2 telephone calls, or IC, consisting of printed educational material. Both interventions were delivered by a nurse clinician. The primary outcome was categorically defined treatment response at 4 weeks, based on sleep questionnaires and diaries. Secondary outcomes included self-report symptom and health measures, sleep diaries, actigraphy, and polysomnography.

Results  Categorically defined response (67% [n = 26] vs 25% [n = 10]; χ2 = 13.8) (P < .001) and the proportion of participants without insomnia (55% [n = 21] vs 13% [n = 5]; χ2 = 15.5) (P < .001) were significantly higher for BBTI than for IC. The number needed to treat was 2.4 for each outcome. No differential effects were found for subgroups according to hypnotic or antidepressant use, sleep apnea, or recruitment source. The BBTI produced significantly better outcomes in self-reported sleep and health (group × time interaction, F5,73 = 5.99, P < .001), sleep diary (F8,70 = 4.32, P < .001), and actigraphy (F4,74 = 17.72, P < .001), but not polysomnography. Improvements were maintained at 6 months.

Conclusion  We found that BBTI is a simple, efficacious, and durable intervention for chronic insomnia in older adults that has potential for dissemination across medical settings.

Trial Registration  clinicaltrials.gov Identifier: NCT00177203

×